# Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluting Everolimus From Cobalt Versus Platinum Alloy Platforms

> **NCT01776567** · PHASE4 · UNKNOWN · sponsor: **Northern Hospital, Australia** · enrollment: 60 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Everolimus eluting stents

## Key facts

- **NCT ID:** NCT01776567
- **Lead sponsor:** Northern Hospital, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07
- **Primary completion:** 2014-12
- **Final completion:** 2015-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2014-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01776567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01776567, "Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluting Everolimus From Cobalt Versus Platinum Alloy Platforms". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01776567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*